Deep Track Capital, LP 13D and 13G filings for Jounce Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 08:50 am Sale |
2023-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
Deep Track Capital, LP | 0 0.000% |
-4,259,653 (Position Closed) |
Filing |
| 2023-02-14 08:40 am Purchase |
2022-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
Deep Track Capital, LP | 4,259,653 8.240% |
259,653 (+6.49%) |
Filing |
| 2022-02-14 08:56 am Purchase |
2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
Deep Track Capital, LP | 4,000,000 7.810% |
143,537 (+3.72%) |
Filing |
| 2021-09-01 4:20 pm Purchase |
2021-08-31 | 13G | Jounce Therapeutics, Inc. JNCE |
Deep Track Capital, LP | 3,856,463 7.530% |
3,856,463 (New Position) |
Filing |